论文部分内容阅读
血脂异常包括高胆固醇血症、高甘油三酯血症、低高密度脂蛋白血症和混合型高脂血症4种类型,其中以低密度脂蛋白胆固醇(LDL-C)增高为主要表现的高胆固醇血症是动脉粥样硬化性心血管疾病(ASCVD,包括冠心病、缺血性卒中以及外周动脉疾病)最重要的危险因素。近30余年来,我国居民中血脂异常的流行趋势日趋严重,对ASCVD的防治形成严峻挑战。为进一步做好血脂异常防治工作,中华医学会心血管病学分会联合中华医学会糖尿病学分会等学术机构组织专家,于2007年制定并颁布了
Dyslipidemia, including hypercholesterolemia, hypertriglyceridemia, low-density lipoproteinemia and mixed type of hyperlipidemia, four types, including low-density lipoprotein cholesterol (LDL-C) increased as the main performance Hypercholesterolemia is the most important risk factor for atherosclerotic cardiovascular disease (ASCVD, including coronary heart disease, ischemic stroke, and peripheral arterial disease). In the past 30 years, the prevalence of dyslipidemia in Chinese residents has become more and more serious, posing a serious challenge to the prevention and treatment of ASCVD. To further the prevention and treatment of dyslipidemia, the Chinese Medical Association of Cardiology branch of the Chinese Medical Association diabetes branch academic institutions and other experts, formulated and promulgated in 2007